BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1-Reference-Cited by-同舟云学术

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1

Published:2016-01-10 Issue:9 Volume:55 Page:1693-1697
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Flint Julia,Panchal Sonia,Hurrell Alice,van de Venne Maud,Gayed Mary,Schreiber Karen,Arthanari Subha,Cunningham Joel,Flanders Lucy,Moore Louise,Crossley Amy,Purushotham Neetha,Desai Amisha,Piper Madeleine,Nisar Mohamed,Khamashta Munther,Williams David,Gordon Caroline,Giles Ian,

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/55/9/1693/18097647/kev404.pdf

Reference4 articles.

1. State of the art: Reproduction and pregnancy in rheumatic diseases

2. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs

3. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice;Flint;Rheumatology,2016

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology;Reumatismo;2024-09-11

2. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases;Journal of Autoimmunity;2024-09

3. Sialylation status in placentas from anti-Ro/SSA- and anti-La/SSB-positive pregnant women;Tissue and Cell;2024-08

4. Successful pregnancy in Takayasu’s arteritis type III with complete infrarenal aortic block;BMJ Case Reports;2024-08

5. Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?;Medicina;2024-07-19